Upadacitinib Kept Atopic Dermatitis Under Control for Most of a Year in Italian Real-World Study
A 52-week Italian real-world study of 433 patients found that upadacitinib kept moderate-to-severe atopic dermatitis in a controlled state for ...
Tag: EASI90
POPULAR NEWS
-
How an industrial apparel brand stitches narrative into fabric, thread and label
-
New Open-Access Journal Biomedical Materials Science Launches to Link Materials Innovation with Patient Care
-
Berberine Eases Diabetic Kidney Damage by Tuning a Renal Sugar-Transport Switch
-
Palmitoylation Enzyme ZDHHC5 Emerges as Driver of Neutrophil Inflammation in COPD